Navigation Links
KalVista Pharmaceuticals and JDRF Form Research Partnership Focused on Novel Approach for Treating Diabetic Eye Disease
Date:1/9/2012

SOUTHAMPTON, ENGLAND and NEW YORK, Jan. 9, 2012 /PRNewswire-USNewswire/ -- KalVista Pharmaceuticals ("KalVista") and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. Diabetic eye disease is one of the most common and most serious complications in people with type 1 diabetes (T1D). JDRF will provide up to $2.2 million in milestone-based financial support and research expertise to KalVista. The goal of this partnership is to advance KalVista's lead pre-clinical candidate, a plasma kallikrein inhibitor, into human proof-of-concept clinical trials and to generate clinical data that would highlight its potential as an entirely new approach to treat diabetic macular edema (DME). DME is a leading cause of visual loss for people with T1D that involves swelling of the retina, which can lead to blurred vision and blindness.

Plasma kallikrein is an enzyme (a serine protease) that has been identified as a potential therapeutic target in people with diabetic retinopathy. Research has shown   that it contributes to increases in blood vessel leakage and thickening of the retina. Previous JDRF-funded studies led by one of KalVista's co-founders, Edward Feener, Ph.D., Associate Professor of Medicine at Harvard Medical School and Joslin Diabetes Center, demonstrated that plasma kallikrein is increased and activated in the vitreous fluid of people with DME . This data suggests that chronic activation of plasma kallikrein increases blood vessel inflammation and permeability by generating the production of a hormone called bradykinin, which causes blood vessels to dilate or enlarge. Plasma kallikrein inhibitors are believed to reduce retinal vessel leakage by suppressing the chronic and excessive production of bradykinin.

"Diabetic eye disease is a high priority research area for JDRF. Our support of Dr. Feener's academic research over the years
'/>"/>

SOURCE JDRF
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
2. Questcor Pharmaceuticals Reports Strong Finish to 2011
3. Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
4. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
7. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
10. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
11. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aug. 1, 2014 MGC Diagnostics Corporation ... announced today that it has completed its acquisition ... cardiorespiratory diagnostic products based in Sorinnes, ... the European cardiorespiratory diagnostics market since 1977. MediSoft, ... approximately €4.7 million ($6.3 million) and incurred a ...
(Date:8/1/2014)... LAWRENCE, Mass. , Aug. 1, 2014  NxStage Medical, ... innovative dialysis products, today announced that Jeffrey H. Burbank ... Financial Officer, will present at the 34 th Annual ... Boston, MA , on Wednesday, August 13 ... event will be made available at http://ir.nxstage.com/ .  ...
(Date:8/1/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... study evaluating ISIS-SMN Rx in infants with spinal ... infant mortality. Isis plans to dose the first infant ... which time Isis will earn an $18 million milestone ... 3 study, ENDEAR, is the first of several planned ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5
... College of American Pathologists Outlines Recommendations at Food and Drug ... , ... increasing importance of laboratory tests in diagnosing and treating disease, representatives ... the Food and Drug Administration (FDA) urging increased oversight of laboratory ...
... CHICAGO and PASADENA, Calif. , July 20 ... that Huntington Memorial Hospital has selected the Allscripts ... Exchange (HIE) that enables physicians, hospitals and other health care providers ... team approach to patient care, regardless of where they are located ...
Cached Medicine Technology:CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 2CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 3CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 2Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 3Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 5Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 6Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 7
(Date:8/1/2014)... New York, NY (PRWEB) August 01, 2014 ... Bryan tickets at Maple Lane Farms in Knoxville/Greenback, TN; ... FL & Whitehurst Cattle Farm in Archer/Gainesville, FL. Luke Bryan ... Night” tour with Lee Brice and Cole Swindell. Bryan is ... in the world each summer and this year, just because ...
(Date:8/1/2014)... have grown in popularity as more and more men ... generally known as BOTOX use has ... emerged to perform procedures utilizing this and other injectables. ... the Division of Plastic Surgery Presbyterian Hospital in New ... in New York have assessed the capability of various ...
(Date:8/1/2014)... of Bioengineering and Nanotechnology (IBN), Singapore General Hospital ... co-developed the first molecular test kit that can ... patients. This breakthrough was recently reported in ... , According to IBN Executive Director Professor ... molecular diagnostics and cancer research, we have developed ...
(Date:8/1/2014)... City, NY (PRWEB) August 01, 2014 With ... two incomes, and the convenience of processed, microwavable dinners, it ... Diet Doc does not offer patients a mere quick fix ... helping everyone, in any part of the country, get slimmer ... if they offer patients the tools and education on ...
(Date:8/1/2014)... Beach, FL (PRWEB) August 01, 2014 ... announced today the opening of a new K-CAPS® ... , The company announced expansion plans last year ... According to Dale Martin, General Manager, “KCAPS® are ... the world.” He added that: “Compared to other ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Plastic surgeons or nurses: Who are the better injectors? 2Health News:Taking the guesswork out of cancer therapy 2Health News:Taking the guesswork out of cancer therapy 3Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3
... 221.10.254.64 Cancer patients may benefit from sessions with ... new Cochrane systematic review shows using music can reduce ... effects on mood, pain and quality of life. ... wide range of clinical settings. Treatments range from patients ...
... By Serena Gordon HealthDay Reporter , TUESDAY, ... apnea have a higher risk of developing mild cognitive impairment ... elderly women who began the study without dementia had 85 ... over the next five years if they had 15 or ...
... (HealthDay News) --,Kids, meals at fast-food restaurants are high ... In fact, researchers from the University of California, ... rewards, accounted for up to 51 percent of most ... of their recommended daily sodium intake (100 percent of ...
... Wasik, MD, professor of Pathology and Laboratory Medicine, and ... the Perelman School of Medicine at the University of ... protein works by silencing the tumor suppressor gene IL-2R ... a recent Proceedings of the National Academy of ...
... TUESDAY, Aug. 9 (HealthDay News) -- People who regularly eat ... a reduced risk of colon polyps, a precursor to colon ... data from 2,818 people who were followed for 26 years. ... among the participants. The risk of polyps was 40 ...
... active are important, but choosing a healthy snack, planning a ... are not always easy for people with limited knowledge and ... throughout the state how to make healthy choices to improve ... obesity rate in Missouri is too high," said Candance Gabel, ...
Cached Medicine News:Health News:Music reduces anxiety in cancer patients 2Health News:Sleep Apnea Could Up Risk of Dementia In Elderly Women 2Health News:Sleep Apnea Could Up Risk of Dementia In Elderly Women 3Health News:More American Kids Eating Fast Food 2Health News:Penn study on silencing of tumor suppressor gene suggests new target for lymphoma 2Health News:High-Fiber Diet Might Lower Risk for Colon Polyps 2Health News:MU programs teach Missouri families to make healthy food choices 2
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... up kit. Includes configured Laptop PC with ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... friendly software. Store/track run data. ... Outstanding uniformity. Advanced control algorithms ...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
PxE thermal Cycler. 0.2ml, 96 well block holds 96 tubes or 1 x 96 well plate. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User f...
Medicine Products: